Nad+ IV Therapies Lyophilized Powder CAS 53-84-9 500mg Nad Kits
TDS 126 Inquiries
53-84-9
Pharmaceutical Grade
99%
guangzhou
NUOCHENJIAN
500mg/vial,10vials/box
Yes
2026-09-10
Peptide,tirzepatide,retatrutide,semaglutide
-
Product Details
-
Seller Information
-
History Price
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceNAD+ is a coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage.
Solid
NAD zwitterion is a NAD. It has a role as a geroprotector. It derives from a deamido-NAD zwitterion. It is a conjugate base of a NAD(+).|A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)|Nadide is a dinucleotide of adenine and nicotinamide. It has coenzyme activity in redox reactions and also acts as a donor of ADP-ribose moieties.Research & Reference NoteNad+ IV Therapies Lyophilized Powder CAS 53-84-9 500mg Nad Kits is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Certificates-
TDS
Basic Info-
Product Name:
NAD
Other Name:Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium,inner salt;Pyridinium,3-carbamoyl-1-β-D-ribofuranosyl-,hydroxide,5′→5′-ester with adenosine 5′-(trihydrogen pyrophosphate),inner salt;Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium hydroxide,inner salt;Codehydrase I;Codehydrogenase I;Coenzyme I;Diphosphopyridine nucleotide;DPN;Cozymase I;NAD;Nadide;Nicotinamide-adenine dinucleotide;Oxidized diphosphopyridine nucleotide;Adenine-nicotinamide dinucleotide;NAD+;Enzopride;β-NAD;β-Diphosphopyridine nucleotide;β-Nicotinamide adenine dinucleotide;β-NAD+;NSC 20272;CO-I;β-Nicotinamide adenine dinucleotide hydrate;30429-30-2;159929-29-0;1083039-67-1;1354693-98-3
CAS No.:53-84-9
Molecular Formula:C21H27N7O14P2
InChIKeys:InChIKey=BAWFJGJZGIEFAR-NNYOXOHSSA-N
Molecular Weight:663.43
Exact Mass:663.109131
EC Number:200-184-4
NSC Number:757121
DSSTox ID:DTXSID2045236
NCI Thesaurus Code:C87339
HScode:29349990
Categories:
Characteristics-
PSA:
321
XLogP3:-1.29620
Appearance:White Powder
Melting Point:140-142 °C (decomp)
Water Solubility:soluble in water at 50mg/ml
Storage Conditions:2-8°C
Specific rotation:D20 -31.5° (c = 1.2 in water)
Collision Cross Section:226.7 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|227.5 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|222.7 Ų [M+Na]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|223.8 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|230.8 Ų [M+Na-2H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|227 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptide,tirzepatide,retatrutide,semaglutide
-
Location:
Room 1503-21, United Building, Building 1, No. 216, Tongchuan Road, Licang District, Qingdao City, Shandong Province
-
Payment Terms:
100% TT in advance
-
Average lead Time:
1 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2025
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Inquiry History126 Inquiries
Country Product Purchase Quantity Date Posted
United States
NAD
1 KG Oct 26, 2026
India
NAD
100 G Oct 21, 2026
India
NAD+
20 G Sep 30, 2026
United States
NAD
30 MT Sep 29, 2026
United Arab Emirates
NAD
10 MT Sep 19, 2026
Australia
NAD
50 PCS Sep 16, 2026
United States
NAD
30 MG Sep 1, 2026
Philippines
NAD+
15 KG Sep 1, 2026
Philippines
NAD+
15 KG Aug 31, 2026
United Kingdom
NAD+ 500mg for IV therapy
2 MG Aug 11, 2026
United States
NAD+
1 G Aug 7, 2026
United States
NAD+ 500mg / 1000mg
100 MG Aug 7, 2026
United States
NAD+
1000 MG Aug 4, 2026
South Africa
Nad+
10 MT Jul 27, 2026
United States
β-Nicotinamide adenine dinucleotide
10 G Jul 16, 2026
Poland
Fenbendazole
1 KG Jul 14, 2026
United States
NAD
10 MT Jul 9, 2026
United States
NAD+ 500
10000 MG Jul 2, 2026
United States
Beta-Nicotinamide adenine dinucleotide Nad+
1 MG Jun 18, 2026
Australia
Nad
10 MG Jun 16, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Mazdutide 10mg Raw Powder CAS Number 2259884-03-0 Door To Door Service
Pharmaceutical Grade / 99%
$102/UNIT FOB
-
-
-
-
Cagrilintide CAS Number 1415456-99-3 Peptide Bulk Shipment White Peptide
Pharmaceutical Grade / 99%
$117/UNIT FOB
-
-
-
-
Selank Freeze Dried Powder Available Price Supplier Long Acting Peptide
Pharmaceutical Grade / 99%
-
-
-
-
Motsc Sealed Vial China Manufacturer Peptide OEM ODM Service
Pharmaceutical Grade / 99%
-
-
-
-
Adipotide Peptide API Powder 2mg/vial Cas 859216-15-2 Laboratory Research
Pharmaceutical Grade / 99%
$90/UNIT FOB
-
-
-
-
Retatrutide Peptide 30mg GMP Direct Supply Quick Shipping
Pharmaceutical Grade / 99%
$165.3/UNIT FOB
-
Hot Related Products
-
β-Nicotinamide Mononucleotide cas 1094-61-7 White to slightly yellow crystalline powder Research and development of customized synthesis -
Premium 99% Niacinamide Mononucleotide Nmn CAS 1094-61-7 -
99% High Purity Anti-aging NMN Raw Powder β-Nicotinamide Mononucleotide CAS 1094-61-7 -
Hot Selling Nmn CAS 1094-61-7 Nicotinamide Mononucleotide β-Nicotinamid Mononucleotide -
Pure 99% Nicotinamide Mononucleotide NMN powder CAS 1094-61-7 with high quatity -
β-Nicotinamide mononucleotide 98% white Powder staherb staherb -
NMN(1094-61-7) -
99.9% Nicotinamide Mononucleotide (NMN) Supplier for Anti Aging steroid 100% Delivery Guarantee raw powder 99% purity -
Bulk Nicotinamide Mononucleotide NMN 1094-61-7$62/KG FOB
-
Cas no. 1094-61-7 BETA-NICOTINAMIDE MONONUCLEOTIDE used as a product of the eNAMPT reaction and a NAD intermediate
